Radalbuvir
Radalbuvir is an experimental antiviral drug developed by Gilead Sciences for the treatment of hepatitis C. It is a nucleotide analogue inhibitor of the Hepatitis C virus NS5B polymerase.
History[edit]
Radalbuvir was first developed by Gilead Sciences, a biopharmaceutical company based in the United States. The drug is currently in the experimental stage and has not yet been approved for use in humans.
Mechanism of Action[edit]
Radalbuvir works by inhibiting the NS5B polymerase of the Hepatitis C virus, which is essential for viral replication. By blocking this enzyme, the drug prevents the virus from multiplying and spreading in the body.
Clinical Trials[edit]
Several clinical trials have been conducted to evaluate the safety and efficacy of Radalbuvir in patients with Hepatitis C. These trials have shown promising results, with many patients achieving a sustained virologic response after treatment with the drug.
Potential Side Effects[edit]
As with all drugs, Radalbuvir may cause side effects in some patients. These can include fatigue, headache, and nausea. However, these side effects are generally mild and manageable.
Future Developments[edit]
Research is ongoing to further evaluate the potential of Radalbuvir in the treatment of Hepatitis C. If successful, this drug could provide a new treatment option for patients with this chronic liver disease.
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Radalbuvir[edit]
-
Radalbuvir
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
